Author

C. Vandenberg

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Assay:DNA methylation· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1

Frequent Co-Authors

E. Lieschke· 2 shared A. Biankin· 1 shared A. DeFazio· 1 shared A. Papenfuss· 1 shared C. L. Scott· 1 shared C. Scott· 1 shared D. Bowtell· 1 shared D. Ennis· 1 shared

Activity by Year

2020-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

E. Lieschke

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Ovarian carcinosarcoma genomics and pre-clinical models highlight the N-MYC pathway as a key driver and susceptibility to EMT-targeting therapy

G. Y. Ho, E. Kyran, J. Bedo, M. Wakefield, D. Ennis, H. Mirza, S. Cooke, E. Lieschke, C. Vandenberg, O. Kondrashova, R. Upstill-Goddard, U.-M. Bailey, S. Biankin, P. Roxburgh, R. Glasspool, , H. Barker

This study identifies N-MYC pathway activation and susceptibility to EMT-targeting therapy in ovarian carcinosarcoma using genomic and pre-clinical models.

bioRxiv · Nov 24, 2020 · PreprintCancer Biology

CHK2 inhibition provides a strategy to suppress hematological toxicity from PARP inhibitors.

Z. Xu, C. Vandenberg, E. Lieschke, C. L. Scott, I. J. Majewski

This study identifies CHK2 inhibition as a strategy to reduce hematological toxicity from PARP inhibitors by targeting the p53 pathway in blood cells.

bioRxiv · Jul 28, 2020Cancer Biology